Docteur JACQUES-ERIC GOTTENBERG
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Direction de thèses
🎓 3 thèses dirigéesIdentification de nouvelles cibles thérapeutiques au cours du syndrome de Gougerot-Sjögren primitif (SJp)
2023Doctorant·e : Renaud Felten
Immunologie🎓 StrasbourgRôle du ''B-cell activating factor'' (BAFF) et des lymphocites B dans la fibrose pulmonaire et cutanée dans la sclérodermie systémique
2013Doctorant·e : Antoine François
Immunologie🎓 StrasbourgRole of salivary gland epithelial cells in the differentiation and activation of T lymphocytes in primary Sjögren's syndrome
2013Doctorant·e : Ya-Zhuo Gong
Immunologie🎓 Strasbourg
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
61
h articles cités ≥ h fois chacun. Un h de 61 = 61 publications avec 61+ citations.
Citations
14 877
Publications
386
i10-index
150
Thématiques principales
- Salivary Gland Disorders and Functions ×118
- Rheumatoid Arthritis Research and Therapies ×91
- Systemic Lupus Erythematosus Research ×82
- Systemic Sclerosis and Related Diseases ×40
- Chronic Lymphocytic Leukemia Research ×35
Affiliations FR : Centre National de la Recherche Scientifique · Centre National de la Recherche Scientifique · Inserm
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
2026ArticleAnnals of the Rheumatic Diseases
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025ArticleThe Lancet Rheumatology
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
2025ArticleJoint Bone Spine
Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture
2025ArticleBMC Medical Education
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
2025ArticleArthritis & rheumatology
Primary Sjögren’s Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
2025ArticleAnnals of the Rheumatic Diseases
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025ArticleInternational Journal of Molecular Sciences
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: data from the French national registry REGATE
2025ArticleJoint Bone Spine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
HOPITAL DE HAUTEPIERRE
1 Avenue MOLIERE, 67200 Strasbourg
☎ 0388116768HospitalierCABINET PRIVE DU DR JACQUES-ERIC GOTTENBERG
HOPITAL DE HAUTEPIERRE, SERVICE DE RHUMATOLOGIE — 1 AVENUE MOLIERE, 67098 Strasbourg
☎ 0388127950Libéral
.jpg)
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (4)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Sciences. Maladie de Sjögren : une avancée thérapeutique majeure portée par un Strasbourgeois - DNA
📰 DNA · 17/12/2025
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNM29VbFRob3ZlS1pXdmYza0xMNGU0TVo4aVVyQXY3UUM2ZW5GSUxmb3lpSGRYYWZxNU50dkFNTFJtelZtTlR4YzlrZWcxTmtvSm00WWZ0OGJqbVZDQXljQTBNWllkUnQ0RU5mZl9IWERyRm5jMk1zRHlwZkloanVSamNIUURwVzVENHAxOFpmQzljNUNIbDktLTBvODl5TVdKMFVTV3BQQTNMcHVfSXZyUUFocVAzN2V4?o
- Mercredi 10 mai 2017 : Journée mondiale du lupus - Salle de presse de l'Inserm
📰 Salle de presse de l'Inserm · 05/05/2017
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOa1g5MkxBcFBIZ1lFRUhhYThuY0NiRDFVeHVTQkRiaDBoWWpTaHhDX1lSdWJIbGRZV3ZtaG5ZOV9vQWh4R3VsdGx3RmNwa2JpYm9DUW5jMy1nNlhqM1F3X0o1cDZSUVh0aTQxa0tXaC1WS2x3WEU4Nm5BRThhM1FiLXNUZVZtWDNKUy1BeUtfU3A?oc=5" target="_blank">Mercredi 10 mai 2017 : Journée m
- RECHERCHE. Les anticorps, ressources inégalables contre le coronavirus - L'Alsace
📰 L'Alsace · 11/12/2020
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOWkJ3aUVUS2pZeklHVzJTZGhhcHp6QkI3MHh0eXRzeEN2SzdUb0l4cFNuMm9VcGl0THhVc1ZxRUxkWlhicmpNRTE3al9KYmlWcHd6T3VxQjBnUTBoRFFhckhFdDBNcG5pb3FZTXpUdzhSOFctWHUxUk5jT1pTNEFGbERUczFDVjNka0RRRFMwRks1Z3dzRjJubWtRQ2lBbDg?oc=5" target="_blank">RECHERCHE. L
- Médecine Une étude made in Strasbourg publiée dans une grande revue. De « Dr House » à Hautepierre - DNA
📰 DNA · 31/07/2014
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE83bEpjbHJDd2tCTVBlMmt0QlVhYzFMc2xoN3ZpUFhTaVhMTmpSVlFaWXI1bG92NU9TbXVsb1NDOUM4RGtPZEUySWUyMlFqaUV4bXJxd3VEeTR5TnE3OC1ORWpoWmJxVHJBMm5kLTNB?oc=5" target="_blank">Médecine Une étude made in Strasbourg publiée dans une grande revue. De « Dr Ho
Top publications · les plus citées
- 1Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
The Lancet. Rheumatology · 2024
📚 56 citations🎯 RCR 13.68Top 2% NIH🔓 Open Access - 22023 International Rome consensus for the nomenclature of Sjögren disease
Nature reviews. Rheumatology · 2025
- 32024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Annals of the rheumatic diseases · 2024
📚 21 citations🎯 RCR 4.79Top 8% NIH
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Sjögren17
▼
Sjögren17
▼- The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms
NPJ systems biology and applications · 2026 · Journal Article
E Silva-Saffar S, Mariette X, Gottenberg JE, Bombardieri M, et al.
- A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
Annals of the rheumatic diseases · 2026 · Journal Article
Beydon M, Dulin M, Ly B, Verstuyft C, et al.
- Nipocalimab for the treatment of moderate-to-severe Sjögren's disease: a plain language summary of the DAHLIAS study
Expert review of clinical immunology · 2026 · Journal Article
Noaiseh G, Sivils KL, Campbell K, Idokogi J, et al.
- Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren's Disease and Association with Patient-Reported Outcomes
Rheumatology and therapy · 2025 · Journal Article
Gottenberg JE, Seror R, Massey N, Hughes M, et al.
- Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
Lancet (London, England) · 2025 · Journal Article
Noaiseh G, Sivils KL, Campbell K, Idokogi J, et al.
📚 10 cit.🎯 RCR 3.89🩺 Clinique - Deep Immunophenotyping and Clustering Identifies Biomarkers Predictive of Lymphoma in Primary Sjögren Disease
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Marques C, Régnier P, Maciejewski-Duval A, Richard de Vesvrotte C, et al.
📚 4 cit. - Cutaneous Vasculitis in Primary Sjögren Disease
JAMA dermatology · 2025 · Journal Article
Breillat P, Le Guern V, d'Humières T, Battistella M, et al.
📚 1 cit. - Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
Annals of the rheumatic diseases · 2025 · Journal Article
Bowman SJ, Seror R, Porcher R, Arends S, et al.
📚 10 cit.🎯 RCR 4.23 - 2023 International Rome consensus for the nomenclature of Sjögren disease
Nature reviews. Rheumatology · 2025 · Consensus Statement
Ramos-Casals M, Baer AN, Brito-Zerón MDP, Hammitt KM, et al.
📚 45 cit.🎯 RCR 18.89🔬→🩺 Translationnel - Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Nguyen Y, Beydon M, Gottenberg JE, Morel J, et al.
📚 12 cit.🎯 RCR 4.86 - Impact of Sjögren's disease on quality of sexual life using the Qualisex score
RMD open · 2025 · Journal Article
Kachaner A, Seror R, Le Guern V, Dieudé P, et al.
- Stability of symptom-based subtypes in Sjogren's disease
RMD open · 2024 · Journal Article
Berry JS, Tarn J, Casement J, Lendrem D, et al.
📚 3 cit. - Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease
RMD open · 2024 · Journal Article
Georgel L, Benyoussef AA, Berrouiguet S, Guellec D, et al.
📚 2 cit.🩺 Clinique - Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study
The Lancet. Rheumatology · 2024 · Journal Article
Rocca J, Beydon M, Le Guern V, Hachulla E, et al.
📚 10 cit.🎯 RCR 2.20🩺 Clinique - Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease
RMD open · 2024 · Journal Article
Felten R, Foray AP, Schneider P, Marquet C, et al.
📚 4 cit. - Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease
Clinical immunology (Orlando, Fla.) · 2024 · Journal Article
Boudjeniba C, Soret P, Trutschel D, Hamon A, et al.
📚 2 cit. - Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
The Lancet. Rheumatology · 2024 · Journal Article
Nguyen Y, Nocturne G, Henry J, Ng WF, et al.
📚 56 cit.🎯 RCR 13.68🔬→🩺 Translationnel
Transversal11
▼
Transversal11
▼- Prescription of Targeted Therapies in patient with a history of cancer
Joint bone spine · 2026 · Journal Article
Sebbag E, Gottenberg JE
- Time and patient journey to axial spondyloarthritis diagnosis: a retrospective study in French primary care
Rheumatology (Oxford, England) · 2026 · Journal Article
Prati C, Constantin A, Dernis E, Gottenberg JE, et al.
- Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
Joint bone spine · 2026 · Journal Article
Juge PA, Debray MP, Pensec VD, Richez C, et al.
- Clinical Images: Sarcoidosis revealed by recurrent dactylitis
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Subervie T, Willaume T, Maazouzi A, Gottenberg JE, et al.
- French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
Joint bone spine · 2025 · Journal Article
Avouac J, Fogel O, Beydon M, Frémont GM, et al.
🩺 Clinique - Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland
Annals of the rheumatic diseases · 2025 · Journal Article
Wiley MM, Radziszewski M, Khatri B, Joachims ML, et al.
📚 4 cit. - Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
International journal of molecular sciences · 2025 · Journal Article
Benezech A, Gottenberg JE, Degboé Y, Kruglov A, et al.
- Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024
Annals of the rheumatic diseases · 2025 · Journal Article
Winthrop KL, Bathon J, Kerschbaumer A, Isaacs JD, et al.
📚 4 cit. - 2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Annals of the rheumatic diseases · 2024 · Journal Article
Sebbag E, Lauper K, Molina-Collada J, Aletaha D, et al.
📚 21 cit.🎯 RCR 4.79🔬→🩺 Translationnel - 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Joint bone spine · 2024 · Journal Article
Fautrel B, Kedra J, Rempenault C, Juge PA, et al.
📚 10 cit.🎯 RCR 2.84🔬→🩺 Translationnel - Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024 · Journal Article
Driouich JS, Cochin M, Lingas G, Luciani L, et al.
📚 2 cit.
Biothérapies non-anti-TNF5
▼
Biothérapies non-anti-TNF5
▼- Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Chevet B, Souki A, Nowak E, Carvajal-Alegria G, et al.
📚 1 cit.🩺 Clinique - Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE
Joint bone spine · 2025 · Journal Article
Morel J, Wetzman A, Wendling D, Soubrier M, et al.
📚 1 cit. - Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
BMJ open · 2025 · Clinical Trial Protocol
Pascart T, Fautrel B, Gottenberg JE, Ducoulombier V, et al.
🩺 Clinique - Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study
Rheumatology and therapy · 2024 · Journal Article
Kivitz A, Gottenberg JE, Bergman M, Qiu C, et al.
📚 2 cit. - Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
Rheumatology (Oxford, England) · 2024 · Journal Article
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, et al.
📚 2 cit.
Essai clinique4
▼
Essai clinique4
▼- Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trials
Human vaccines & immunotherapeutics · 2026 · Journal Article
Yu F, Myshkin E, Nguyen B, Bobadilla Mendez C, et al.
- Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial
The Lancet. Rheumatology · 2026 · Journal Article
Courties A, Tuffet S, Cormier G, Roux CH, et al.
🩺 Clinique - Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture
BMC medical education · 2025 · Journal Article
Felten R, Bigaut K, Wirth T, Kremer L, et al.
📚 1 cit.🩺 Clinique - Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
Revue générale4
▼
Revue générale4
▼- Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy
Autoimmunity reviews · 2025 · Journal Article
Lignou AZ, Vassilakis KD, Baraliakos X, Sfikakis PP, et al.
📚 8 cit.🎯 RCR 3.10 - Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Annals of the rheumatic diseases · 2025 · Journal Article
Sebbag E, Molina-Collada J, Ndoye R, Aletaha D, et al.
📚 10 cit.🎯 RCR 4.40🔬→🩺 Translationnel - Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals
Advances in therapy · 2025 · Journal Article
Spinner CD, Bell S, Einsele H, Tremblay C, et al.
📚 7 cit.🎯 RCR 3.01🔬→🩺 Translationnel - iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review
Stem cell research & therapy · 2024 · Journal Article
Ali EAM, Smaida R, Meyer M, Ou W, et al.
📚 17 cit.🎯 RCR 4.18
Pharmacovigilance3
▼
Pharmacovigilance3
▼- Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
Annals of the rheumatic diseases · 2026 · Journal Article
Scherlinger M, Dieudonné Y, Hilliquin S, Chatelus E, et al.
- Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy
Autoimmunity reviews · 2025 · Journal Article
Lignou AZ, Vassilakis KD, Baraliakos X, Sfikakis PP, et al.
📚 8 cit.🎯 RCR 3.10 - Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
Rheumatology (Oxford, England) · 2024 · Case Reports
Sztejkowski C, Sibilia J, Danion F, Mertz P, et al.
JAK inhibiteurs2
▼
JAK inhibiteurs2
▼- Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
RMD open · 2024 · Journal Article
Buch MH, Aletaha D, Combe BG, Tanaka Y, et al.
📚 4 cit.🎯 RCR 1.18🩺 Clinique - Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Annals of the rheumatic diseases · 2024 · Journal Article
Burmester GR, Gottenberg JE, Caporali R, Winthrop KL, et al.
📚 13 cit.🎯 RCR 2.56🔬→🩺 Translationnel
Lupus2
▼
Lupus2
▼- Novel vascular damage markers in SLE: insights from carotid colour Doppler ultrasound and aortic oscillometry in the LUPCARD cohort
RMD open · 2025 · Journal Article
Triantafyllias K, Tietze F, Bertsias G, Gottenberg JE, et al.
- Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients
Cells · 2024 · Journal Article
Aubergeon L, Felten R, Gottenberg JE, Dumortier H, et al.
📚 4 cit.
Anti-TNF1
▼
Anti-TNF1
▼- Acute myocarditis after switching between two adalimumab biosimilars
Rheumatology (Oxford, England) · 2026 · Journal Article
Subervie T, Sauer F, Von Hunolstein JJ, Sebbag E, et al.
Case report / série1
▼
Case report / série1
▼- Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
Annals of the rheumatic diseases · 2026 · Journal Article
Scherlinger M, Dieudonné Y, Hilliquin S, Chatelus E, et al.
Corticothérapie1
▼
Corticothérapie1
▼- Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial
Annals of the rheumatic diseases · 2025 · Journal Article
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, et al.
📚 8 cit.🎯 RCR 3.62🩺 Clinique
csDMARDs1
▼
csDMARDs1
▼- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet. Rheumatology · 2025 · Journal Article
Morel J, Dernis E, Roux C, Richez C, et al.
📚 2 cit.🩺 Clinique
Économie santé1
▼
Économie santé1
▼- Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals
Advances in therapy · 2025 · Journal Article
Spinner CD, Bell S, Einsele H, Tremblay C, et al.
📚 7 cit.🎯 RCR 3.01🔬→🩺 Translationnel
Épidémiologie & registres1
▼
Épidémiologie & registres1
▼- Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
RMD open · 2025 · Journal Article
Triboulet F, Juge PA, Truchetet ME, Pham T, et al.
📚 6 cit.🎯 RCR 2.47🩺 Clinique
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Annals of the rheumatic diseases · 2025 · Journal Article
Sebbag E, Molina-Collada J, Ndoye R, Aletaha D, et al.
📚 10 cit.🎯 RCR 4.40🔬→🩺 Translationnel
Datasets & protocoles partagés
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
Collection2021figshareAbstract Background The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COV
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France
Collection2021figshareAbstract Background The risk of severe COVID-19 and its determinants remain largely unknown in patients with autoimmune and inflammatory rheumatic diseases. The objective of this study was to assess the prevalence of COV
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Audiovisual2021Adis Journals<strong>Article full text</strong> The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
Collection2023figshareAbstract Background Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying a
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
Collection2023figshareAbstract Background Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying a
Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection
Audiovisual2021Adis Journals<strong>Article full text</strong> <br> The above summary slide represents the opinions of the <b>authors</b>. For a full list of declarations, including funding and author disclosure statements, please see the full text
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).